DM
RVNC

Deerfield Management’s Revance Therapeutics, Inc. RVNC Stock Holding History

Deerfield Management’s Portfolio RVNC Stock Details RVNC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q4 		– Sell
-870,000
Closed -$9.98M – 233
2023
Q3 		$9.98M Hold
870,000
– – 0.22% 57
2023
Q2 		$22M Buy
+870,000
New +$27.1M 0.47% 45
2020
Q1 		– Sell
-900,000
Closed -$14.6M – 100
2019
Q4 		$14.6M Buy
+900,000
New +$14M 0.47% 56
2018
Q1 		– Sell
-1,000,000
Closed -$35.8M – 126
2017
Q4 		$35.8M Buy
+1,000,000
New +$28.7M 1.41% 25
2014
Q3 		– Sell
-256,500
Closed -$8.72M – 146
2014
Q2 		$8.72M Buy
256,500
+139,811
+120% +$4.38M 0.35% 70
2014
Q1 		$3.68M Buy
+116,689
New +$3.65M 0.15% 98

Other funds holding RVNC

Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
PAI
Palo Alto Investors Palo Alto, California $654M AUM 77.8% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
PCH
Polar Capital Holdings London, United Kingdom $28.2B AUM 115.26% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return